Thursday, October 20, 2016

Mega pharma mergers haven’t brought value: CEO

Actelion wants to create value in its industry and the best way is to innovate as well as discover and develop new drugs says CEO, Jean-Paul Clozel, when weighing in on potential M&A opportunities.

from Mergers and Acquisitions http://ift.tt/2ew7EyS

No comments:

Post a Comment